We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
106 hedge funds and large institutions have $473M invested in Larimar Therapeutics in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
905% more call options, than puts
Call options by funds: $3.29M | Put options by funds: $328K
21% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 33
2.66% more ownership
Funds ownership: 99.71% → 102.36% (+2.7%)
2% more funds holding
Funds holding: 104 → 106 (+2)
9% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 22
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less capital invested
Capital invested by funds: $483M → $473M (-$9.4M)
Holders
106
Holders Change
+2
Holders Change %
+1.92%
% of All Funds
1.53%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
40
Reduced
33
Closed
22
Calls
$3.29M
Puts
$328K
Net Calls
+$2.97M
Net Calls Change
-$4.86M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$7.01M |
| 2 |
BlackRock
New York
|
+$6.09M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.02M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$3.29M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$2.73M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$8.88M |
| 2 |
RI
RTW Investments
New York
|
-$4.93M |
| 3 |
Renaissance Technologies
New York
|
-$1.72M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.6M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.32M |
